1 Min Read
May 5 (Reuters) - Eyegate Pharmaceuticals Inc
* Sees secondary offering of its common stock of 5.3 million shares - sec filing Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.